Online apps make it easy to track metrics, such as Body weight Calories consumed Steps Exercise Medication side effects Mood As you track your progress, set goals, and celebrate when you achieve them
Strength training determines which scenario you get
It is a once-weekly investigational triple agonist designed to activate three metabolic receptor pathways at the same time: GLP-1, GIP, and glucagon
Therefore, given the rarity of suicidal or self-harming behaviors, the limited sample size of the RCT, and the inherent limitations of retrospective studies, comprehensive research with long-term follow-up and rigorous mental health assessments is needed to clarify the potential risks and benefits
According to the SURMOUNT-1 clinical trial, patients using tirzepatide at the highest dose (15 mg weekly) experienced up to 22.5% total body weight loss over 72 weeksgreater than what is typically seen with semaglutide GLP-1
While not yet FDA-approved or available for patient use, this method could represent a future option for patients seeking alternatives to injections